| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 411.37B | 422.70B | 409.84B | 395.16B | 358.75B | 385.98B |
| Gross Profit | 118.88B | 121.87B | 123.25B | 102.55B | 78.81B | 50.47B |
| EBITDA | 94.08B | 95.67B | 95.91B | 74.74B | 55.80B | 27.39B |
| Net Income | 40.77B | 51.96B | 81.53B | 40.74B | 12.12B | -39.80B |
Balance Sheet | ||||||
| Total Assets | 1.30T | 1.30T | 1.30T | 1.28T | 1.29T | 1.33T |
| Cash, Cash Equivalents and Short-Term Investments | 38.48B | 35.03B | 60.66B | 67.60B | 21.98B | 49.40B |
| Total Debt | 614.61B | 610.60B | 629.03B | 705.12B | 755.30B | 781.70B |
| Total Liabilities | 816.28B | 820.73B | 841.40B | 891.48B | 935.97B | 974.54B |
| Stockholders Equity | 480.76B | 478.28B | 459.32B | 387.39B | 346.86B | 349.88B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -52.25B | 11.29B | 14.90B | -24.86B | -33.48B |
| Operating Cash Flow | 0.00 | 55.88B | 71.63B | 62.93B | 48.62B | 27.18B |
| Investing Cash Flow | 0.00 | -74.50B | 23.43B | 34.71B | -45.52B | -43.58B |
| Financing Cash Flow | 0.00 | -7.04B | -102.08B | -51.06B | -30.57B | 37.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥4.02T | 16.15 | 7.85% | 1.69% | 4.61% | 5.75% | |
72 Outperform | ¥608.79B | 8.33 | 13.92% | 1.50% | 6.30% | -16.29% | |
72 Outperform | ¥343.69B | 9.85 | ― | 1.61% | 6.55% | -12.49% | |
66 Neutral | ¥1.43T | 10.37 | 11.29% | 3.00% | 5.48% | 33.67% | |
65 Neutral | ¥584.32B | 12.46 | 8.51% | 2.96% | -2.82% | -50.73% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥554.20B | 5.46 | 9.94% | 2.49% | 1.72% | 10.19% |